Brown Seaweed Food Supplementation: Effects on Allergy and Inflammation and Its Consequences

S.E.M. Olsthoorn, X. Wang, B. Tillema, T. Vanmierlo, S. Kraan, P.J.M. Leenen, M.T. Mulder*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Citations (Web of Science)

Abstract

Multiple health benefits have been ascribed to brown seaweeds that are used traditionally as dietary component mostly in Asia. This systematic review summarizes information on the impact of brown seaweeds or components on inflammation, and inflammation-related pathologies, such as allergies, diabetes mellitus and obesity. We focus on oral supplementation thus intending the use of brown seaweeds as food additives. Despite the great diversity of experimental systems in which distinct species and compounds were tested for their effects on inflammation and immunity, a remarkably homogeneous picture arises. The predominant effects of consumption of brown seaweeds or compounds can be classified into three categories: (1) inhibition of reactive oxygen species, known to be important drivers of inflammation; (2) regulation, i.e., in most cases inhibition of proinflammatory NF-kappa B signaling; (3) modulation of adaptive immune responses, in particular by interfering with T-helper cell polarization. Over the last decades, several inflammation-related diseases have increased substantially. These include allergies and autoimmune diseases as well as morbidities associated with lifestyle and aging. In this light, further development of brown seaweeds and seaweed compounds as functional foods and nutriceuticals might contribute to combat these challenges.
Original languageEnglish
Article number2613
Number of pages59
JournalNutrients
Volume13
Issue number8
DOIs
Publication statusPublished - 1 Aug 2021

Keywords

  • seaweed
  • allergy
  • inflammation
  • oral
  • MOLECULAR-WEIGHT FUCOIDAN
  • SARGASSUM-FUSIFORME POLYSACCHARIDES
  • VIVO ANTIINFLAMMATORY ACTIVITIES
  • NONSPECIFIC IMMUNE-RESPONSE
  • RAW 264.7 MACROPHAGES
  • DIET-INDUCED OBESITY
  • FATTY LIVER-DISEASE
  • IN-VITRO
  • SULFATED POLYSACCHARIDE
  • ANTIOXIDANT ACTIVITIES

Cite this